...
首页> 外文期刊>International Journal of Medical Sciences >Ulinastatin Preconditioning Attenuates Inflammatory Reaction of Hepatic Ischemia Reperfusion Injury in Rats via High Mobility Group Box 1(HMGB1) Inhibition
【24h】

Ulinastatin Preconditioning Attenuates Inflammatory Reaction of Hepatic Ischemia Reperfusion Injury in Rats via High Mobility Group Box 1(HMGB1) Inhibition

机译:乌司他丁预处理可通过高迁移率族框1(HMGB1)抑制减弱大鼠肝缺血再灌注的炎症反应

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective It has been found that ulinastatin (UTI) can attenuate hepatic injury in a rat model of ischemia reperfusion (IR), but the specific mechanism is unclear. This study aims to investigate possible pathomechanism of ulinastatin in reducing the inflammatory response after hepatic IR. Methods A male sprague-dawley(SD) rat model of hepatic ischemia reperfusion injury was used. The rats were randomly divided into 4 groups on average, which were 0.9% saline and IR group as control, ulinastatin preconditioning (UPC) group, UPC+rHMGB1 (recombinant HMGB1) group and UPC +anti-HMGB1 group. Serum aminotransferases, TNF-α, IL-1 and Myeloperoxidase (MPO) levels were measured. Histopathology examination and apoptotic cell detection and the different expression of HMGB1 protein were also assessed. Results Serum levels of aminotransferases, cytokines and hepatic MPO in UPC and UPC+anti-HMGB1 groups were significantly lower than those in control group (pConclusions HMGB1 expressions in UPC and UPC+anti-HMGB1 groups were significantly lower than those in the two control groups (p<0.05), pretreatment with ulinastatin attenuated liver IR injury by reducing HMGB1 expression through its anti-inflammatory effects.
机译:目的已发现乌司他丁(UTI)可以减轻大鼠缺血再灌注(IR)模型的肝损伤,但具体机制尚不清楚。这项研究的目的是研究乌司他丁在减轻肝脏IR后的炎症反应中可能的致病机理。方法采用雄性sprague-dawley(SD)大鼠肝缺血再灌注损伤模型。将大鼠平均随机分为4组,分别以0.9%生理盐水和IR组为对照组,乌司他丁预处理(UPC)组,UPC + rHMGB1(重组HMGB1)组和UPC +抗HMGB1组。测量血清氨基转移酶,TNF-α,IL-1和髓过氧化物酶(MPO)的水平。还评估了组织病理学检查和凋亡细胞检测以及HMGB1蛋白的不同表达。结果UPC和UPC + anti-HMGB1组的血清氨基转移酶,细胞因子和肝MPO水平明显低于对照组(p结论:UPC和UPC + anti-HMGB1组的HMGB1表达明显低于两个对照组。 (p <0.05),用乌司他丁预处理可通过降低HMGB1的抗炎作用来减轻肝脏IR损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号